NurExone Biologic Inc. (NRX.V)
TSXV · CAD · Healthcare · Biotechnology
CA$0.51 (+2.00%) as of
Key statistics
- Market cap
- 46.94M
- Forward P/E
- -6.17
- EPS (TTM)
- -0.1100
- Dividend yield
- 0.00%
- 52-week range
- 0.4350 – 0.7600
- Beta
- 0.33
- Profit margin
- 0.00%
- Volume
- 5.19k
About NurExone Biologic Inc.
NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It offers ExoPTEN, for treatment of acute spinal cord injuries. The company was founded in 2020 and is based in Toronto, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Toronto, ON, Canada
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.